Why the Johns Hopkins results stood out
In the Johns Hopkins study, 24 adults with long-term major depressive disorder received two psilocybin sessions within a carefully structured program of preparation and supportive psychotherapy. Four weeks after treatment, most participants showed substantial improvement and half were in remission.
Alan Davis, Ph.D., the study’s lead author, said the magnitude of the effect was about four times larger than clinical trials had shown for traditional antidepressants on the market. He described the findings as a potential “game changer” if they continued to hold up in placebo-controlled studies.
That comparison is why the research attracted so much attention. It was not simply a report that people felt better for a day or had an interesting experience. Researchers measured clinically meaningful changes in depressive symptoms after a brief, highly supported course of psilocybin treatment.
What remained one year later
Johns Hopkins researchers continued following participants after the initial study. At 12 months, depression severity scores remained low overall. Seventy-five percent of participants met the study’s definition of treatment response, and 58% were in remission.
These longer-term findings strengthened the importance of the original results. They suggested that, for many participants, the emotional shift was not limited to the hours of the psilocybin experience or the first weeks afterward.
The whole therapeutic protocol mattered
The Johns Hopkins research did not study psilocybin as an isolated pill taken without context. Participants were prepared before the sessions, supported during them and invited to process the experience afterward. The environment, therapeutic relationship, intention and integration were part of the method researchers studied.
This is one reason preparation and integration are so central to thoughtfully held plant-assisted work. A powerful experience can open perception and emotion; the surrounding process helps a person make meaning, recognize new possibilities and carry insight into everyday choices, relationships and patterns.
What this means for people exploring plant-assisted healing
The Johns Hopkins findings helped bring psychedelic therapy into serious conversations about depression, emotional healing and the limits of conventional approaches. They also showed why the quality of the experience surrounding psilocybin matters.
At Healing Rituals, the journey begins before the deeper session. A 60–90 minute introductory experience brings together sound, gentle breath, Quantum Subconscious Reprogramming and passive energy clearing so intentions can become clear and the setting can feel familiar, beautiful and deeply supported.
For clients traveling to Aspen or the Roaring Fork Valley, preparation and integration can be shaped around the larger arc of the experience—not only the central journey. The intention is to create room for insight to become embodied change, with practices and personalized support that continue beyond the session itself.
Sources & further reading
- Johns Hopkins Medicine: Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ShowsStudy results and the four-times-larger comparison
- Johns Hopkins Medicine: Psilocybin Treatment for Major Depression Effective for Up to a Year for Most PatientsTwelve-month follow-up findings
- Johns Hopkins Center for Psychedelic and Consciousness ResearchResearch center overview
Explore the experience
Learn how preparation, Quantum Subconscious Reprogramming, sound, energy work and integration are woven into private plant-assisted healing journeys.
Explore plant-assisted journeys